High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,620
-10 (-0.08%)
At close: Nov 17, 2025
-0.08%
Market Cap128.45B
Revenue (ttm)74.65B
Net Income (ttm)10.56B
Shares Out10.63M
EPS (ttm)991.66
PE Ratio12.18
Forward PEn/a
Dividend100.00 (0.83%)
Ex-Dividend DateDec 27, 2024
Volume21,920
Average Volume29,296
Open12,630
Previous Close12,630
Day's Range12,310 - 12,680
52-Week Range11,130 - 16,430
Beta0.76
RSI40.17
Earnings DateNov 12, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.